Ivy Emerging Markets Equity is a reasonable offering, but better options exist. Most of its share classes maintain their Morningstar Analyst Ratings of Neutral, while the very expensive B share class falls to Negative.
Ivy Emerging Markets Equity A IPOAX
NAV / 1-Day Return
29.41
/
0.07
%
Total Assets
2.5 Bil
Adj. Expense Ratio
Adjusted Expense Ratio excludes certain variable investment-related expenses, such as interest from borrowings and dividends on borrowed securities, allowing for more consistent cost comparisons across funds.
1.460%
Expense Ratio
1.460%
Fee Level
Average
Longest Manager Tenure
7.24
years
Category
Diversified Emerging Mkts
Investment Style
Large GrowthMin. Initial Investment
750
Status
Open
TTM Yield
0.70%
Turnover
32%
Premium
Morningstar’s Analysis
The Morningstar Analysis section contains a thorough evaluation of an investment’s merits and drawbacks and often discusses the most important or decisive factors leading to the fund’s overall rating.
The Morningstar Analysis section contains a thorough evaluation of an investment’s merits and drawbacks and often discusses the most important or decisive factors leading to the fund’s overall rating.
Will IPOAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
The Process Pillar is our assessment of how sensible, clearly defined, and repeatable IPOAX’s performance objective and investment process is for both security selection and portfolio construction.
People Pillar
The People Pillar is our evaluation of the IPOAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of IPOAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
An emerging-markets equity offering with some outstanding questions.
